Medicon Ireland Ltd iXBRL


Relate AccountsProduction v2.3.3 v2.3.3 2019-01-01 The company was not dormant during the period The company was trading for the entire period The principal activity of the company is the distribution of medical diagnostics, the supply of software and the wholesale supply of pharmaceutical products. 4 August 2020 0 0 NI058603 2019-12-31 NI058603 2018-12-31 NI058603 2017-12-31 NI058603 2019-01-01 2019-12-31 NI058603 2018-01-01 2018-12-31 NI058603 uk-bus:PrivateLimitedCompanyLtd 2019-01-01 2019-12-31 NI058603 uk-bus:AbridgedAccounts 2019-01-01 2019-12-31 NI058603 uk-core:ShareCapital 2019-12-31 NI058603 uk-core:ShareCapital 2018-12-31 NI058603 uk-core:RetainedEarningsAccumulatedLosses 2019-12-31 NI058603 uk-core:RetainedEarningsAccumulatedLosses 2018-12-31 NI058603 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2019-12-31 NI058603 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2018-12-31 NI058603 uk-bus:FRS102 2019-01-01 2019-12-31 NI058603 uk-core:VehiclesPlantMachinery 2019-01-01 2019-12-31 NI058603 uk-core:PlantMachinery 2019-01-01 2019-12-31 NI058603 uk-core:FurnitureFittingsToolsEquipment 2019-01-01 2019-12-31 NI058603 uk-core:MotorVehicles 2019-01-01 2019-12-31 NI058603 uk-bus:Audited 2019-01-01 2019-12-31 NI058603 2019-01-01 2019-12-31 NI058603 uk-bus:Director1 2019-01-01 2019-12-31 xbrli:pure iso4217:GBP xbrli:shares
Company Number: NI058603
 
 
Medicon Ireland Ltd
 
Abridged Financial Statements
 
for the financial year ended 31 December 2019
Medicon Ireland Ltd
Company Number: NI058603
ABRIDGED STATEMENT OF FINANCIAL POSITION
as at 31 December 2019

2019 2018
Notes £ £
 
Non-Current Assets
Intangible assets 6 1,500 3,000
Property, plant and equipment 7 61,344 71,853
───────── ─────────
62,844 74,853
───────── ─────────
 
Current Assets
Stocks 49,359 90,804
Debtors 397,946 676,628
Cash and cash equivalents 493,464 424,721
───────── ─────────
940,769 1,192,153
───────── ─────────
Creditors: Amounts falling due within one year (345,071) (659,207)
───────── ─────────
Net Current Assets 595,698 532,946
───────── ─────────
Total Assets less Current Liabilities 658,542 607,799
 
Creditors
Amounts falling due after more than one year (8,477) -
 
Provisions for liabilities (8,163) (8,962)
───────── ─────────
Net Assets 641,902 598,837
═════════ ═════════
 
Capital and Reserves
Called up share capital 2 2
Income statement 641,900 598,835
───────── ─────────
Equity attributable to owners of the company 641,902 598,837
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.
           
The company has taken advantage of the exemption under section 444 not to file the Abridged Income Statement and Director's Report.
           
Approved by the Director and authorised for issue on 4 August 2020
           
           
________________________________          
Mr. Patrick I. McGowan          
Director          



Medicon Ireland Ltd
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
for the financial year ended 31 December 2019

   
1. GENERAL INFORMATION
 
Medicon Ireland Ltd is a company limited by shares incorporated in Northern Ireland. 16 Mount Charles, Belfast, BT7 1NZ is the registered office, 1a/1b, Carnbane Business Park, Newry BT35 6QH is the principal place of business of the company . The nature of the company's operations and its principal activities are set out in the Director's Report. The financial statements have been presented in Pound Sterling (£) which is also the functional currency of the company.
         
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the year ended 31 December 2019 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.

The going concern basis assumes that the company will continue in operational existence for the foreseeable future, having adequate funds to meet its obligations as they fall due.

The company generates income from the distribution of medical diagnostics, the supply of software and the wholesale supply of pharmaceutical, which has been  impacted by the current, unprecedented challenges posed by the COVID-19 pandemic.

After making enquiries and considering the uncertainties described above, the directors have a reasonable expectation that the company will have adequate resources to continue in operation existence for the foreseeable future.
 
Turnover
Turnover represents the total invoice value, excluding value added tax, of sales made during the year and derives from the provision of goods falling within the company's ordinary activities.
 
Property, plant and equipment and depreciation
Property, plant and equipment are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of property, plant and equipment, less their estimated residual value, over their expected useful lives as follows:
 
  Short leasehold property - 2% Straight line
  Plant and machinery - 15% Straight line
  Fixtures, fittings and equipment - 25% Reducing balance
  Motor vehicles - 25% Straight line
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Leasing and hire purchases
Property, plant and equipment held under leasing and Hire Purchases arrangements which transfer substantially all the risks and rewards of ownership to the company are capitalised and included in the Statement of Financial Position at their cost or valuation, less depreciation. The corresponding commitments are recorded as liabilities. Payments in respect of these obligations are treated as consisting of capital and interest elements, with interest charged to the Income Statement.
 
Leasing
Rentals payable under operating leases are dealt with in the Income Statement as incurred over the period of the rental agreement.
 
Stocks
Stocks are valued at the lower of cost and net realisable value. Stocks are determined on a first-in first-out basis. Cost comprises expenditure incurred in the normal course of business in bringing stocks to their present location and condition.  Full provision is made for obsolete and slow moving items. Net realisable value comprises actual or estimated selling price (net of trade discounts) less all further costs to completion or to be incurred in marketing and selling.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Borrowing costs
Borrowing costs relating to the acquisition of assets are capitalised at the appropriate rate by adding them to the cost of assets being acquired. Investment income earned on the temporary investment of specific borrowings pending their expenditure on the assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.
 
Provisions
Provisions are recognised when the company has a present legal or constructive obligation arising as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation and a reliable estimate can be made. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current market assessments of the same value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognised as interest expense.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Employee benefits
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The company also operates a defined benefit pension scheme for its employees providing benefits based on final pensionable pay. The assets of this scheme are also held separately from those of the company, being invested with pension fund managers.
 
Taxation and deferred taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Statement of Financial Position date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
 
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Statement of Financial Position date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Income Statement.
 
Intangible assets
Intangible assets are valued at cost less accumulated amortisation.
 
Amortisation is calculated to write off the cost in equal annual instalments over their estimated useful life of 4 years.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
   
3. SIGNIFICANT ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY
 
The preparation of financial statements requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, income and expenses. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects that period. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial period are described below.


(i) Going concern assumption

As outlined in the accounting policies, current events and conditions related to the Covid-19 pandemic represent a material uncertainty that may cast significant doubt on the entity’s ability to continue as a going concern. The directors have made enquiries and considered the uncertainties but have a reasonable expectation that the company will have adequate resources to continue in operational existence for the foreseeable future.
   
4. INFORMATION RELATING TO THE AUDITOR'S REPORT
 
The Audit Report was unqualified. There were no matters to which the auditor was required to refer by way of emphasis.
 
The financial statements were audited by Muldoon & Co.
The Auditor's Report was signed by Mr Robert Barr (Senior Statutory Auditor) for and on behalf of Muldoon & Co on 4th August 2020.
 
       
5. EMPLOYEES
 
The average monthly number of employees, including director, during the financial year was 10, (2018 - 11).
       
6. INTANGIBLE FIXED ASSETS
     
    Total
  £ £
Cost
At 1 January 2019 6,000 6,000
  ───────── ─────────
 
At 31 December 2019 6,000 6,000
  ───────── ─────────
Amortisation
At 1 January 2019 3,000 3,000
Charge for financial year 1,500 1,500
  ───────── ─────────
At 31 December 2019 4,500 4,500
  ───────── ─────────
Net book value
At 31 December 2019 1,500 1,500
  ═════════ ═════════
At 31 December 2018 3,000 3,000
  ═════════ ═════════
             
7. PROPERTY, PLANT AND EQUIPMENT
  Short Plant and Fixtures, Motor Total
  leasehold machinery fittings and vehicles  
  property   equipment    
  £ £ £ £ £
Cost or Valuation
At 1 January 2019 89,554 4,850 143,369 24,367 262,140
Additions - - - 14,470 14,470
Disposals - - - (12,000) (12,000)
  ───────── ───────── ───────── ───────── ─────────
At 31 December 2019 89,554 4,850 143,369 26,837 264,610
  ───────── ───────── ───────── ───────── ─────────
Depreciation
At 1 January 2019 68,619 3,063 104,223 14,382 190,287
Charge for the financial year 5,511 358 9,787 4,524 20,180
On disposals - - - (7,201) (7,201)
  ───────── ───────── ───────── ───────── ─────────
At 31 December 2019 74,130 3,421 114,010 11,705 203,266
  ───────── ───────── ───────── ───────── ─────────
Net book value
At 31 December 2019 15,424 1,429 29,359 15,132 61,344
  ═════════ ═════════ ═════════ ═════════ ═════════
At 31 December 2018 20,935 1,787 39,146 9,985 71,853
  ═════════ ═════════ ═════════ ═════════ ═════════
           
7.1. PROPERTY, PLANT AND EQUIPMENT CONTINUED
 
Included above are assets held under finance leases or hire purchase contracts as follows:
 
  2019   2018  
  Net Depreciation Net Depreciation
  book value charge book value charge
  £ £ £ £
 
Motor vehicles 11,757 2,713 - -
  ═════════ ═════════ ═════════ ═════════
   
8. EVENTS AFTER END OF REPORTING PERIOD
 
After the balance sheet date, the company’s trading activities were adversely impacted by the effects of the Covid-19 pandemic. The impact is ongoing and wide-reaching; therefore it is not possible to quantify the financial impact of the event.